Research Progress on the Relationship between Endometriosis and Ovarian Cancer

Abstract

Abstract: Endometriosis (EMs) is a benign gynecological disease with malignant behavior. Epidemiological and pathological studies have confirmed that EMs can increase the risk of ovarian cancer, especially clear cell cancer and endometrioid cancer. In recent years, reports on endometriosis associated ovarian cancer (EAOC) have been increasing both at home and abroad. Researches have confirmed that EAOC is a specific type of ovarian cancer. The research on the etiology, pathogenesis and clinical characteristics of EAOC has become a hot spot. Through reading a large number of literatures, this paper analyzed the risk factors, pathogenesis, clinical characteristics and diagnostic methods of EAOC reported so as to improve the understanding of the disease.

Key words: Endometriosis, Ovarian neoplasms, Risk factors, Pathogenesis, Clinical features, Diagnosis

MEN Wen-ting，HAN Chun-ying，LIU Shan-shan，WANG Qu-yuan. Research Progress on the Relationship between Endometriosis and Ovarian Cancer[J]. Journal of International Obstetrics and Gynecology, 2019, 46(2): 138-141.

References

1. N. Krawczyk, M. Banyspaluchowski, D. Schmidt, U. Ulrich, T. Fehm, Endometriosis-associated Malignancy. Geburtshilfe Und Frauenheilkunde 76, 176 (2016). 2. B. M. Reid, J. B. Permuth, T. A. Sellers, Epidemiology of ovarian cancer: a review. Cancer Biology & Medicine 14, 9-32 (2017). 3. J. A. Sampson, ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN. American Journal of Obstetrics & Gynecology 9, 111-114 (1925). 4. R. B. Scott, Malignant changes in endometriosis. Obstetrics & Gynecology 2, 283 (1953). 5. M. Matalliotakis et al., Association between ovarian cancer and advanced endometriosis. Oncol Lett 15, 7689-7692 (2018). 6. M. A. Wilbur, I. M. Shih, J. H. Segars, A. N. Fader, Cancer Implications for Patients with Endometriosis. Seminars in Reproductive Medicine 35, 110-116 (2017). 7. J. P. Stamp et al., BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer. International Journal of Gynecological Cancer 26, 825-832 (2016). 8. L. Saraswat et al., Impact of endometriosis on risk of further gynaecological surgery and cancer: a national cohort study. BJOG 125, 64-72 (2018). 9. A. J. Chiang et al., Risk factors in progression from endometriosis to ovarian cancer: a cohort study based on medical insurance data. J Gynecol Oncol 29, e28 (2018). 10. T. Huang et al., Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies. Gynecologic Oncology 139, 481-486 (2015). 11. H. Kapoor, D. K. Agrawal, S. K. Mittal, Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny. Translational Research 166, 28 (2015). 12. S. Muangtan, W. Suknikhom, P. Sananpanichkul, K. Bhamarapravatana, K. Suwannarurk, Epithelial Ovarian Cancer with Endometriosis is not Associated with Menopausal Status: a Co-Association Study at Prapokklao Hospital. Asian Pac J Cancer Prev 19, 1337-1341 (2018). 13. E. Haidarali et al., Evaluation of the Pathogenesis of Tumor Development from Endometriosis by Estrogen Receptor, P53 and Bcl-2 Immunohistochemical Staining. Asian Pacific Journal of Cancer Prevention Apjcp 17, 6147 (2016). 14. L. H. Thomsen et al., Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review. Acta Obstet Gynecol Scand 96, (2016). 15. F. Taniguchi, New knowledge and insights about the malignant transformation of endometriosis. Journal of Obstetrics & Gynaecology Research 43, 1093 (2017). 16. K. C. Wiegand et al., ARID1A mutations in endometriosis-associated ovarian carcinomas. New England Journal of Medicine 363, 1532-1543 (2010). 17. K. Levanon, C. Crum, R. Drapkin, New insights into the pathogenesis of serous ovarian cancer and its clinical impact. Journal of Clinical Oncology 26, 5284-5293 (2008). 18. G. Singer, R. J. Kurman, H. W. Chang, S. K. Cho, S. Iem, Diverse tumorigenic pathways in ovarian serous carcinoma. American Journal of Pathology 160, 1223-1228 (2002). 19. N. Sato et al., Loss of Heterozygosity on 10q23.3 and Mutation of the Tumor Suppressor Gene PTEN in Benign Endometrial Cyst of the Ovary: Possible Sequence Progression from Benign Endometrial Cyst to Endometrioid Carcinoma and Clear Cell Carcinoma of the Ovary. Cancer Research 60, 7052 (2000). 20. R. C. Wu, T. L. Wang, S. Iem, The emerging roles of ARID1A in tumor suppression. Cancer Biology & Therapy 15, 655-664 (2014). 21. L. Zhao et al., Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis. Journal of the National Cancer Institute 106, 766-776 (2014). 22. M. S. Anglesio et al., Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. Journal of Pathology 236, 201-209 (2015). 23. A. Dawson, M. L. Fernandez, M. Anglesio, P. J. Yong, M. S. Carey, Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development. Ecancermedicalscience 12, 803 (2018). 24. J. P. Stamp et al., BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer. Int J Gynecol Cancer 26, 825-832 (2016). 25. K. Nishikimi, T. Kiyokawa, S. Tate, M. Iwamoto, M. Shozu, ARID1A Expression in Ovarian Clear Cell Carcinoma with an Adenofibromatous Component. Histopathology 67, 866-871 (2016). 26. G. M. Borrelli et al., (Partial) Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes. Molecular Human Reproduction 22, (2016). 27. S. Burghaus et al., Genetic risk factors for ovarian cancer and their role for endometriosis risk. Gynecologic Oncology 145, 142-147 (2017). 28. A. W. Lee et al., Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril 105, 35-43 e31-10 (2016). 29. S. Suryawanshi et al., Complement Pathway is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer. Clinical Cancer Research An Official Journal of the American Association for Cancer Research 20, 6163-6174 (2014). 30. A. W. Lee et al., Evidence of a genetic link between endometriosis and ovarian cancer. Fertility & Sterility 105, 35-43 (2016). 31. Y. Lu et al., Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics 24, 5955 (2015). 32. C. Tomasetti, B. Vogelstein, Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78 (2015). 33. O. L. Braicu et al., miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples. Oncotargets & Therapy 10, 4225-4238 (2017). 34. L. N. Heidemann, D. Hartwell, C. H. Heidemann, K. M. Jochumsen, The relation between endometriosis and ovarian cancer - a review. Acta Obstetricia Et Gynecologica Scandinavica 93, 20 (2014). 35. E. S. Paik et al., Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. J Gynecol Oncol 29, e18 (2018). 36. H. S. Kim et al., Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis. Annals of Surgical Oncology 22, 1-8 (2015). 37. D. Bassiouny et al., Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics. Int J Gynecol Pathol, (2018). 38. A. Barreta et al., Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis. Int J Gynecol Cancer 28, 1251-1257 (2018). 39. X. R. Xu, X. Wang, H. Zhang, M. Y. Liu, Q. Chen, The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer. Cancer Biomark 21, 471-477 (2018). 40. M. A. Fraser, S. Agarwal, I. Chen, S. S. Singh, Routine vs. expert-guided transvaginal ultrasound in the diagnosis of endometriosis: A retrospective review. Abdominal Imaging 40, 587-594 (2015). 41. Y. Tanase, R. Kawaguchi, J. Takahama, H. Kobayashi, Factors that Differentiate between Endometriosis-associated Ovarian Cancer and Benign Ovarian Endometriosis with Mural Nodules. Magn Reson Med Sci 17, 231-237 (2018). 42. H. Yang et al., A mass spectrometric insight into the origins of benign gynecological disorders. Mass Spectrometry Reviews 36, 450 (2015). 43. S. Perakis, M. R. Speicher, Emerging concepts in liquid biopsies. Bmc Medicine 15, 75 (2017). 44. A. M. Di, J. Bartlett, Y. Cheng, M. D. Pasic, G. M. Yousef, Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Molecular Cancer 16, 80 (2017). 45. M. Offin et al., Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA. Journal of Oncology,2017,(2017-3-14) 2017, 1-5 (2017). 46. G. Kezia, G. Jane, P. Kirstin, R. Gillian, Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type. International Journal of Cancer 138, 1076-1084 (2016). 47. G. Chene et al., [Current surgical practice of prophylactic and opportunistic salpingectomy in France]. Gynecol Obstet Fertil, 377-384 (2016). 48. G. Chene et al., [Is endometriosis a precancerous lesion? Perspectives and clinical implications]. Gynecologie Obstetrique & Fertilite, (2016). 49. J. S. Kwon, Ovarian cancer risk reduction through opportunistic salpingectomy. Journal of Gynecologic Oncology 26, 83 (2015). 50. R. Tai, S. Choi, P. C. Coyte, The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer. Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC 40, (2017). 51. S. E. Dilley et al., Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention. Gynecologic Oncology 146, 373 (2017). 52. J. S. Kwon et al., Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy. Obstetrics & Gynecology 125, 338-345 (2015). 53. R. Manchanda, R. Legood, A. C. Antoniou, V. S. Gordeev, U. Menon, Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis. Journal of Medical Genetics 53, jmedgenet-2016-103800 (2016). 54. W. H. Parker et al., Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstetrics & Gynecology 121, 709-716 (2013).

[1]	WU Hua-tuo, HUANG Chun-lin, MA Yan, GE Ting, LI Li. Research Progress on the Immune Microenvironment of Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 297-301.
[2]	YANG Yan, YAN Kai, ZHOU Deng-lian, DENG Xin. Exosomes in Endometrial Fibrosis: Mechanisms and Potential Diagnostic and Therapeutic Applications [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 335-340.
[3]	ZHENG Ping, ZHAO Li-ming, ZHANG Xue-fang, GU Bin, YOU Ai-hong, LANG Jing-he, LENG Jin-hua, LIU Chong-dong. Transcranial Direct Current Stimulation Alleviates Endometriosis-Related Pain by Inhibiting NLRP3 Inflammasome Activation [J]. Journal of International Obstetrics and Gynecology, 2026, 53(3): 352-356.
[4]	HAN Zhao-xun, ZHOU Ye. Research Progress on Oxidative Stress Mechanisms and Antioxidant Therapy in Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 125-130.
[5]	ZHANG Chun-jie, WU Li-xian, YANG Bo, LIU Zhi-jie, ZHENG Jing. A Case of Atypical McCune-Albright Syndrome in A Prepubertal Girl [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 150-152.
[6]	ZHANG En-jie, YIN Cheng-hong, LIU Rui-xia, ZHU Hui-ping, LIU Jian-hui, XIE Shuang-hua, SU Shao-fei. Association between Periconceptional Risk Factors Exposure and Early Pregnancy Abortion: A Prospective Study Based on the Chinese Birth Cohort [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 177-183.
[7]	XU Meng-ting, LU Di, SONG Dian-rong. Research Progress in the Tumor Microenvironment of Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 188-193.
[8]	ZHANG Yan, SONG Shu-fang. Advances in the Application of DNA Methylation in Cervical Lesions [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 206-210.
[9]	WANG Ju-peng, REN Li, MA Ming-kun, ZHAO Ran, WEN Xue-hong. Expression Characteristics of KRT18 in Ovarian Cancer and Its Association with Patient Survival and Tumor Immune Microenvironment [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 211-219.
[10]	WANG Si-yao, LING Fei-fei, LI Hong-li, LIU Chang. A Case Report of Hypercalcemic Type Small Cell Carcinoma of the Fallopian Tube [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 232-236.
[11]	ZHANG Meng-jie, JIAO Jin-wen, WANG Li-ming. A Case of Port Site Metastasis Secondary to Abdominal Paracentesis Drainage in Advanced Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2026, 53(2): 237-240.
[12]	WANG Jin-xia, WANG Hai-yan, QI Ya-ling, LIU Yang, LIU Hui-ling. Generation and Gynecologic Tumor Applications of Single-Chain Antibodies [J]. Journal of International Obstetrics and Gynecology, 2026, 53(1): 1-7.
[13]	WANG Peng-yuan, YI Feng-xin, CHI Yun-qian, ZHANG Zi-han, WANG Yun-he, ZHANG Xing-ying, HAO Wei. Transient Neonatal Myasthenia Gravis of Maternal Origin: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2026, 53(1): 117-120.
[14]	XU Tian, PING Yi. Research Progress on Non-Coding RNAs Regulation of Ferroptosis in Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2026, 53(1): 12-17.
[15]	ZHANG Yan, SONG Shu-fang. The Value of p16/Ki-67 Dual Staining Technique in the Triage Diagnosis of Cervical Lesions [J]. Journal of International Obstetrics and Gynecology, 2026, 53(1): 18-21.